Skip to main content
QGEN
NYSE Life Sciences

Qiagen Beats Q3 Outlook, Suspends 2026 Guidance Pending EQT Takeover

Tom Rudovsky · Reported by Reuters
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$50.9
Mkt Cap
$10.496B
52W Low
$32.53
52W High
$57.815
52W Position info
56% above low
Off High info
12% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

QGEN sits 56% above its 52-week low of $32.53.

Summary

Qiagen beat its own Q3 outlook: net sales rose 3% year over year to $548 million and adjusted diluted EPS came in at $0.65, with adjusted operating income margin at 30.4%. Consumables, 91% of sales, grew 3% CER while instruments added 1%; the growth pillars rose 7% CER to $415 million, offset by a 7% CER decline across the rest of the portfolio. The company suspended its 2026 guidance because of the pending EQT Private Equity transaction — the definitive agreement at €46.50 a share in cash was signed October 21 and unanimously approved by both boards. With the stock trading near the deal price, the beat is largely a confirmation of the base business rather than a re-rating event; the guidance suspension removes the standalone outlook as a swing factor. The deal terms, not the quarterly numbers, remain what sets the share price from here.

At the time of this announcement, QGEN was trading at $50.90 on NYSE in the Life Sciences sector, with a market capitalization of approximately $10.5B. The 52-week trading range was $32.53 to $57.82. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

QGEN - Latest Insights

QGEN
Oct 22, 2026, 1:35 AM EDT
Source: dpa-AFX
Importance Score:
9
Price at Filing: $50.27
Real-time Price: $48.70 info
Change: -$1.57 (-3%) info
Market Cap: $10.248B info
QGEN
Oct 21, 2026, 6:11 PM EDT
Filing Type: SC14D9C
Importance Score:
9
Price at Filing: $50.65
Real-time Price: $48.70 info
Change: -$1.95 (-4%) info
Market Cap: $10.248B info
QGEN
Oct 21, 2026, 3:52 PM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $49.97
Real-time Price: $48.70 info
Change: -$1.27 (-3%) info
Market Cap: $10.248B info
QGEN
Oct 20, 2026, 12:45 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $49.30
Real-time Price: $48.70 info
Change: -$0.600 (-1%) info
Market Cap: $10.248B info
QGEN
Sep 28, 2026, 1:30 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $44.18
Real-time Price: $48.70 info
Change: +$4.52 (+10%) info
Market Cap: $10.248B info